Highly purified cytokine activating factor and methods of use
US6420337B1 · kind B1 · utility
5Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2000 |
| Grant date | Jul 16, 2002 |
| Priority date | — |
| Expiry date | Jul 20, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/853
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an isolated Cytokine Activating Factor (CAF) protein, an isolated nucleic acid molecule encoding a CAF protein, an antibody that selectively binds to a CAF protein, a composition comprising a Cytokine Activating Factor (CAF), and a method for modulating the immune system using the composition. Also disclosed is a method for treating cancer using such a composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.